Simon Kohl, a former DeepMind scientist and co-developer of AlphaFold, has raised $50 million to launch Latent Labs, a startup focused on using artificial intelligence to design new proteins. The company aims to revolutionize drug development by replacing traditional experimental methods with AI-driven protein design. With the funding round completed in December, Latent Labs has now secured a total of $50 million to scale its operations and is assembling a team of top AI and biotech researchers in London and San Francisco.
Company Information
Company
Latent Labs
Location
London, England, United Kingdom
About
Latent Labs is an AI foundation model builder focused on programmable biology. Founded by Dr. Simon Kohl, the company aims to empower researchers to computationally create new therapeutic molecules like antibodies and enzymes. Their platform provides tools that expedite drug development timelines and improve the success rates of finding therapeutic molecules. With a team composed of talent from leading tech and biotech firms, Latent Labs is pioneering advancements in generative biology.
LondonBiotechnologyArtificial IntelligenceTherapeutics